Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 13.13
- Piotroski Score 7.00
- Grade Sector Perform
- Symbol (RMD)
- Company ResMed Inc.
- Price $243.54
- Changes Percentage (0.82%)
- Change $1.99
- Day Low $240.69
- Day High $243.73
- Year High $260.49
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
- Last Earnings 10/24/2024
- Ex-Dividend for 5/16 Dividend 11/07/2024
- Dividend Payable 12/12/2024
- Today N/A
- Next Earnings (Estimated) 01/22/2025
- Fiscal Year End N/A
- Average Stock Price Target $224.00
- High Stock Price Target $280.00
- Low Stock Price Target $175.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $6.50
- Trailing P/E Ratio 32.45
- Forward P/E Ratio 32.45
- P/E Growth 32.45
- Net Income $1.02 B
Income Statement
Quarterly
Annual
Latest News of RMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
When to Take Your First RMD: A Guide to Getting It Right
Required minimum distributions (RMDs) are mandatory withdrawals from retirement accounts starting in your 70s. Under the SECURE 2.0 Act, the RMD age will increase to 75 in 2033. RMD amount is based on...
By Yahoo! Finance | 5 days ago -
KORU Medical Systems Inc (KRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
The delay in the next-generation pump launch is due to consumables, not the pump itself. The new pump is expected to launch in early 2025, with a 510(k) submission by mid-2025. This delay won't signif...
By Yahoo! Finance | 1 week ago -
I'm 60 With $750k in my 401(k). Should I Convert $75,000 per Year to Avoid RMDs in Retirement?
SmartAsset and Yahoo Finance may earn commission from links. Converting 401(k) funds to Roth can avoid RMDs, but there are upfront tax implications. Consider consulting a financial advisor to assess i...
By Yahoo! Finance | 2 weeks ago
